Long term conservation of human metabolic phenotypes and link to heritability

Metabolomics

Volumn 10, Issue 5, 2014, Pages 1005-1017

  Yousri, Noha A ^a,b   Kastenmüller, Gabi ^c   Gieger, Christian ^c   Shin, So Youn ^f,h   Erte, Idil ^g   Menni, Cristina ^g   Peters, Annette ^c   Meisinger, Christa ^c   Mohney, Robert P ^d   Illig, Thomas ^e   Adamski, Jerzy ^c   Soranzo, Nicole ^f   Spector, Tim D ^g   Suhre, Karsten ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b Alexandria University The Faculty Of Engineering   (Egypt)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d METABOLON INC   (United States)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Heritability; Longitudinal study; Metabolomics; Population study

Indexed keywords

1, 5 ANHYDROSORBITOL; 2 OXOISOCAPROIC ACID; ANDROSTERONE DERIVATIVE; BIOLOGICAL MARKER; CARNITINE; CITRIC ACID; CITRULLINE; DOCOSAHEXAENOIC ACID; ISOLEUCINE; KYNURENINE; LONG CHAIN FATTY ACID; PROLINE; PYRUVIC ACID; SEROTONIN; THROMBOXANE B2; UNCLASSIFIED DRUG; URATE; VALINE;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; BLOOD SAMPLING; CONSERVATION METABOLITE; FEMALE; GERMANY; HEALTH CARE; HEALTH STATUS; HERITABILITY; HUMAN; INDIVIDUALITY; LONGITUDINAL STUDY; MALE; METABOLITE; METABOLOMICS; PHENOTYPE; POPULATION RESEARCH; PRINCIPAL COMPONENT ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84894278501     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-014-0629-y     Document Type: Article

References (46)

1. Amara, A. W., & Standaert, D. G. (2013). Metabolomics and the search for biomarkers in Parkinson's disease. Movement Disorders, 28(12), 1620-1621. doi: 10. 1002/mds. 25644.
2. Andrew, T., Hart, D. J., Snieder, H., de Lange, M., Spector, T. D., & MacGregor, A. J. (2001). Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Research, 4(6), 464-477.
3. Assfalg, M., Bertini, I., Colangiuli, D., Luchinat, C., Schafer, H., Schutz, B., et al. (2008). Evidence of different metabolic phenotypes in humans. Proceedings of the National Academy of Sciences USA, 105(5), 1420-1424. doi: 10. 1073/pnas. 0705685105.
4. Bernini, P., Bertini, I., Luchinat, C., Nepi, S., Saccenti, E., Schafer, H., et al. (2009). Individual human phenotypes in metabolic space and time. Journal of Proteome Research, 8(9), 4264-4271. doi: 10. 1021/pr900344m.
5. Boker, S., Neale, M., Maes, H., Wilde, M., Spiegel, M., Brick, T., et al. (2011). OpenMx: An open source extended structural equation modeling framework. Psychometrika, 76(2), 306-317. doi: 10. 1007/s11336-010-9200-6.
6. Bollard, M. E., Stanley, E. G., Lindon, J. C., Nicholson, J. K., & Holmes, E. (2005). NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR in Biomedicine, 18(3), 143-162. doi: 10. 1002/nbm. 935.
7. Buse, J. B., Freeman, J. L., Edelman, S. V., Jovanovic, L., & McGill, J. B. (2003). Serum 1, 5-anhydroglucitol (GlycoMark): A short-term glycemic marker. Diabetes Technology and Therapeutics, 5(3), 355-363. doi: 10. 1089/152091503765691839.
8. Cipriani, S., Chen, X., & Schwarzschild, M. A. (2010). Urate: A novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomarkers in Medicine, 4(5), 701-712. doi: 10. 2217/bmm. 10. 94.
9. Corona, G., Rizzolio, F., Giordano, A., & Toffoli, G. (2012). Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets. Journal of Cellular Physiology, 227(7), 2827-2831. doi: 10. 1002/jcp. 24003.
10. Dallmann, R., Viola, A. U., Tarokh, L., Cajochen, C., & Brown, S. A. (2012). The human circadian metabolome. Proceedings National Academy of Sciences USA, 109(7), 2625-2629. doi: 10. 1073/pnas. 1114410109.
11. Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., & Milgram, E. (2009). Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical Chemistry, 81(16), 6656-6667. doi: 10. 1021/ac901536h.
12. Fave, G., Beckmann, M., Lloyd, A. J., Zhou, S., Harold, G., Lin, W., et al. (2011). Development and validation of a standardized protocol to monitor human dietary exposure by metabolite fingerprinting of urine samples. Metabolomics, 7(4), 469-484. doi: 10. 1007/s11306-011-0289-0.
13. Fiehn, O. (2002). Metabolomics-The link between genotypes and phenotypes. Plant Molecular Biology, 48(1-2), 155-171.
14. Gavaghan, C. L., Holmes, E., Lenz, E., Wilson, I. D., & Nicholson, J. K. (2000). An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: Application to the C57BL10J and Alpk: ApfCD mouse. FEBS Letters, 484(3), 169-174.
15. German, J. B., Bauman, D. E., Burrin, D. G., Failla, M. L., Freake, H. C., King, J. C., et al. (2004). Metabolomics in the opening decade of the 21st century: Building the roads to individualized health. Journal of Nutrition, 134(10), 2729-2732.
16. Griffin, J. L., & Shockcor, J. P. (2004). Metabolic profiles of cancer cells. Nature Reviews Cancer, 4(7), 551-561. doi: 10. 1038/nrc1390.
17. Gu, H., Pan, Z., Xi, B., Hainline, B. E., Shanaiah, N., Asiago, V., et al. (2009). 1H NMR metabolomics study of age profiling in children. NMR in Biomedicine, 22(8), 826-833. doi: 10. 1002/nbm. 1395.
18. Halama, A., Riesen, N., Moller, G., Hrabe de Angelis, M., & Adamski, J. (2013). Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: Tools for individualized medicine. Journal of Internal Medicine, 274(5), 425-439. doi: 10. 1111/joim. 12117.
19. Heinzmann, S. S., Merrifield, C. A., Rezzi, S., Kochhar, S., Lindon, J. C., Holmes, E., et al. (2012). Stability and robustness of human metabolic phenotypes in response to sequential food challenges. Journal of Proteome Research, 11(2), 643-655. doi: 10. 1021/pr2005764.
20. Holle, R., Happich, M., Lowel, H., & Wichmann, H. E. (2005). KORA-A research platform for population based health research. Gesundheitswesen, 67(Suppl 1), S19-S25. doi: 10. 1055/s-2005-858235.
21. Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K., Chan, Q., et al. (2008a). Human metabolic phenotype diversity and its association with diet and blood pressure. Nature, 453(7193), 396-400. doi: 10. 1038/nature06882.
22. Holmes, E., Wilson, I. D., & Nicholson, J. K. (2008b). Metabolic phenotyping in health and disease. Cell, 134(5), 714-717.
23. Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008). Metabolomics: A global biochemical approach to drug response and disease. Annual Review of Pharmacology and Toxicology, 48, 653-683. doi: 10. 1146/annurev. pharmtox. 48. 113006. 094715.
24. Kettunen, J., Tukiainen, T., Sarin, A. P., Ortega-Alonso, A., Tikkanen, E., Lyytikainen, L. P., et al. (2012). Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nature Genetics, 44(3), 269-276. doi: 10. 1038/ng. 1073.
25. Kochhar, S., Jacobs, D. M., Ramadan, Z., Berruex, F., Fuerholz, A., & Fay, L. B. (2006). Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Analytical Biochemistry, 352(2), 274-281. doi: 10. 1016/j. ab. 2006. 02. 033.
26. Krug, S., Kastenmuller, G., Stuckler, F., Rist, M. J., Skurk, T., Sailer, M., et al. (2012). The dynamic range of the human metabolome revealed by challenges. The Faseb Journal, 26(6), 2607-2619. doi: 10. 1096/fj. 11-198093.
27. Langley, R. J., Tsalik, E. L., van Velkinburgh, J. C., Glickman, S. W., Rice, B. J., Wang, C., et al. (2013). An integrated clinico-metabolomic model improves prediction of death in sepsis. Science Translational Medicine, 5(195), 195ra195. doi: 10. 1126/scitranslmed. 3005893.
28. Lenz, E. M., Bright, J., Wilson, I. D., Morgan, S. R., & Nash, A. F. (2003). A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. Journal of Pharmaceutical and Biomedical Analysis, 33(5), 1103-1115.
29. Lindon, J. C., Holmes, E., & Nicholson, J. K. (2006). Metabonomics techniques and applications to pharmaceutical research and development. Pharmaceutical Research, 23(6), 1075-1088. doi: 10. 1007/s11095-006-0025-z.
30. Martinez-Lozano Sinues, P., Kohler, M., & Zenobi, R. (2013). Human breath analysis may support the existence of individual metabolic phenotypes. PLoS ONE, 8(4), e59909. doi: 10. 1371/journal. pone. 0059909.
31. Menni, C., Fauman, E., Erte, I., Perry, J. R., Kastenmuller, G., Shin, S. Y., et al. (2013). Biomarkers for type 2 diabetes and impaired fasting glucose using a non-targeted metabolomics approach. Diabetes,. doi: 10. 2337/db13-0570.
32. Nicholson, G., Rantalainen, M., Maher, A. D., Li, J. V., Malmodin, D., Ahmadi, K. R., et al. (2011). Human metabolic profiles are stably controlled by genetic and environmental variation. Molecular System Biology, 7, 525. doi: 10. 1038/msb. 2011. 57.
33. Rasmussen, L., Savorani, F., Larsen, T., Dragsted, L., Astrup, A., & Engelsen, S. (2011). Standardization of factors that influence human urine metabolomics. Metabolomics, 7(1), 71-83. doi: 10. 1007/s11306-010-0234-7.
34. Rathmann, W., Haastert, B., Icks, A., Lowel, H., Meisinger, C., Holle, R., et al. (2003). High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia, 46(2), 182-189. doi: 10. 1007/s00125-002-1025-0.
35. Sampson, J. N., Boca, S. M., Shu, X. O., Stolzenberg-Solomon, R. Z., Matthews, C. E., Hsing, A. W., et al. (2013). Metabolomics in epidemiology: Sources of variability in metabolite measurements and implications. Cancer Epidemiology Biomarkers and Prevention, 22(4), 631-640. doi: 10. 1158/1055-9965. epi-12-1109.
36. Saude, E., Adamko, D., Rowe, B., Marrie, T., & Sykes, B. (2007). Variation of metabolites in normal human urine. Metabolomics, 3(4), 439-451. doi: 10. 1007/s11306-007-0091-1.
37. Suhre, K., Meisinger, C., Doring, A., Altmaier, E., Belcredi, P., Gieger, C., et al. (2010). Metabolic footprint of diabetes: A multiplatform metabolomics study in an epidemiological setting. PLoS ONE, 5(11), e13953. doi: 10. 1371/journal. pone. 0013953.
38. Suhre, K., Shin, S. Y., Petersen, A. K., Mohney, R. P., Meredith, D., Wagele, B., et al. (2011a). Human metabolic individuality in biomedical and pharmaceutical research. Nature, 477(7362), 54-60. doi: 10. 1038/nature10354.
39. Suhre, K., Shin, S. Y., Petersen, A. K., Mohney, R. P., Meredith, D., Wagele, B., et al. (2011b). Human metabolic individuality in biomedical and pharmaceutical research. Nature, 477(7362), 54-60. doi: 10. 1038/nature10354.
40. Wallace, M., Hashim, Y. Z., Wingfield, M., Culliton, M., McAuliffe, F., Gibney, M. J., et al. (2010). Effects of menstrual cycle phase on metabolomic profiles in premenopausal women. Human Reproduction, 25(4), 949-956. doi: 10. 1093/humrep/deq011.
41. Walsh, M. C., Brennan, L., Malthouse, J. P., Roche, H. M., & Gibney, M. J. (2006). Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. American Journal of Clinical Nutrition, 84(3), 531-539.
42. Wang, T. J., Ngo, D., Psychogios, N., Dejam, A., Larson, M. G., Vasan, R. S., et al. (2013). 2-Aminoadipic acid is a biomarker for diabetes risk. Journal of Clinical Investigation, 123(10), 4309-4317. doi: 10. 1172/JCI64801.
43. Wichmann, H. E., Gieger, C., & Illig, T. (2005). KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen, 67(Suppl 1), S26-S30. doi: 10. 1055/s-2005-858226.
44. Winnike, J. H., Busby, M. G., Watkins, P. B., & O'Connell, T. M. (2009). Effects of a prolonged standardized diet on normalizing the human metabolome. American Journal of Clinical Nutrition, 90(6), 1496-1501. doi: 10. 3945/ajcn. 2009. 28234.
45. Zhang, A., Sun, H., & Wang, X. (2012). Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Applied Biochemistry and Biotechnology, 168(6), 1718-1727. doi: 10. 1007/s12010-012-9891-5.
46. Zyphur, M. J., Zhang, Z., Barsky, A. P., & Li, W.-D. (2013). An ACE in the hole: Twin family models for applied behavioral genetics research. The Leadership Quarterly, 24(4), 572-594. doi: 10. 1016/j. leaqua. 2013. 04. 001.